Featured Industry Insights
Latest Industry Insights

Industry Insight
The Probiotic Designed To Work When Your Gut Is Under Attack
Technology Networks spoke with Dr. Jenny Bailey Cooper, co-founder and CEO of Ferryx, to learn the science behind its lead product, FerrocalmTM, and how its innovative strategy could reshape the future of gut health.

Industry Insight
Presenting a Universal Cell Engineering Solution
Portal Bio’s microfluidic technology enhances drug discovery and cell engineering by enabling efficient, scalable molecular delivery for sensitive cell types.

Industry Insight
Bacteria-Based Technology Could Revolutionize Solid Tumor Treatment
At the BioTrinity 2025 conference, Technology Networks spoke with Dr. Pedro Correa de Sampaio, co-founder and CEO of Neobe, who are utilizing synthetic biology to engineer bacteria capable of breaking down the barriers within tumors.

Industry Insight
How Radiopharmaceuticals Are Revolutionizing Cancer Therapy
In this article, Technology Networks spoke with Dr. Jack Hoppin and Dr. John Babich from Ratio Therapeutics to learn more about the recent radiopharmaceutical revolution.

Industry Insight
Unlocking the Potential of PROTACs in Drug Discovery
To explore how PROTACs are transforming drug discovery, we spoke with Robyn Stoller, business development manager at Cytiva.

Industry Insight
Overcoming the Complexities of Antibody-Drug Conjugate Development
In this interview, Technology Networks spoke with Dr. Lena Jonsson, product strategy manager at Cytiva, to explore the biological, clinical and technological frontiers shaping the next generation of ADCs.

Industry Insight
Tick-Borne Illness Diagnosis Enters New Era With Multiplex Testing
Technology Networks spoke to Jason Barker, ND, clinical lab educator at Vibrant Wellness, to explore why co-infections from tick bites are frequently underdiagnosed and to examine current and future testing protocols of tick-borne diseases.

Industry Insight
A New Approach to Treating Osteoarthritis
In this interview, Technology Networks spoke with Dr. Francesco Dell’Accio and Dr. Suzanne Eldridge to explore the impact of osteoarthritis on patients, the goals of ReFleks and a novel approach to repairing osteochondral defects.

Industry Insight
Enhancing Drug Screening With Human-Relevant Models
In this interview, Sebastiaan J. Trietsch, Chief Technology Officer at MIMETAS, discusses how microphysiological systems are advancing drug discovery through scalable human-relevant models and AI integration.

Industry Insight
European Consortium Will Advance Long-Read Sequencing in Clinics
A new pan-European network will integrate long-read sequencing into clinical practice, improving diagnosis of rare diseases and cancers.
Advertisement